The importance of reducing hospitalisations in PAH.

28 August 2017 (13:00 - 13:15)

Organised by:

About the speaker

Professor Jean-Luc Vachiery

Erasme Academic Hospital, Brussels (Belgium)

4 More presentations in this session

Presentation thumbnail

Introduction - Can you achieve more for your pulmonary arterial hypertension (PAH) patients? An expert review of key recent data with initial combination therapy.

Professor I. Lang (Vienna, AT)

Presentation thumbnail

Risk stratification in PAH: are any of our patients really "low risk"?

Professor I. Lang (Vienna, AT)

Presentation thumbnail

Can your connective tissue disease-associated PAH patients achieve similar outcomes to your idiopathic PAH patients?

Doctor J. Coghlan (London, GB)

Presentation thumbnail

Q&A - Can you achieve more for your PAH patients? An expert review of key recent data with initial combination therapy.

Professor I. Lang (Vienna, AT)

Access the full session

Session thumbnail

Can you achieve more for your pulmonary arterial hypertension (PAH) patients? An expert review of key recent data with initial combination therapy

The Event

ESC Congress 2017

28 August 2017 13:00 CET

You may be interested in

Congress Presentation

Unveiling the true burden of hospitalizations in pulmonary arterial hypertension: a comprehensive follow-up analysis

20 March 2026

Congress Session

No time like the present: heart failure in the hospital setting

30 August 2024

Webinar

What's new in the diagnosis and treatment of pulmonary hypertension, Part 2. Understanding specific aspects of congenital heart disease, chronic thromboembolic PH, and the patient's voice

20 December 2022

Congress Presentation

Remote pulmonary artery pressure monitoring

21 May 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources